Technological Innovation and Social Change

go to this page to locate links to the following papers.

:: Study Summaries [pdf 234kb]


:: "The use of flexibilities in TRIPS by developing countries: can they promote access to medicines?" by Cecilia Oh & Sisule Musungu
(now available)

:: "Case Studies: developing innovative capacity in developing countries to meet their health needs" by MIHR
(now available)

:: "Economic aspects of access to medicines after 2005" by Padmashree Sampath
(now available)

:: "How does the regulatory framework affect incentives for research and development" by Precious Matsoso, Martin Auton, Shabir Banoo, Henry Fomundam, Henry Leng, Sassan Noazin
(now available)

:: "Health Innovation Systems in Developing Countries: Towards a Global Strategy for Capacity Building" by John Mugabe
(now available)

:: "Intellectual Property Issues: Public-private partnerships (PPPs)" by Jon Merz
(now available)

:: "Intellectual Property Rights and Technology Transfer: Enabling Access For Developing Countries" by Anthony D. So, Arti K. Rai, Robert M. Cook-Deegan

:: "Implications of Product Patents – Lessons from Japan" by Reiko Aoki
(now available)

:: "Pharmaceutical innovation and the burden of disease in developing and developed countries" by Frank R. Lichtenberg
(now available)

:: Pharmaceutical Tariffs: What is their effect on prices, protection of local industry and revenue generation? by Müge Olcay & Richard Laing
(now available)

:: "Statistical Trends in Pharmaceutical Research for Poor Countries" by Jean Lanjouw & Margarate MacLeod
(now available)

:: "Public-Private Partnerships for Product Development: Financial, scientific and managerial issues as challenges to future success" by Elizabeth Ziemba
(now available)

:: "A Framework for Developing a Research Agenda for Diseases Disproportianately Affecting the Poor: The Cases of Malaria, Diabetes and Rotavirus by Alyna Smith
(now available)

:: "Patents, Price Controls and Access to New Drugs: How Policy Affects Global Market Entry" by Jean Lanjouw
(now available)

:: "R&D for Development for Neglected Diseases. How Can India Contribute" by Sudip Chaudhuri
(now available)

:: "A Review of IP and Non-IP Incentives for R&D for Diseases of Poverty.What Type of Innovation is Required and How Can We Incentivise the Private Sector to Deliver It?" by Adrian Towse
(now available)

:: "The Right Tool(s): Designing Cost-Effective Strategies for Neglected Disease Research" by Stephen Maurer
(now available)

:: "Traditional Medicine: Modern Approach For Affordable Global Health" by Bhushan Patwardhan
(now available)

:: "Traditional medicine could make “Health for One” true" by Qian Jia
(now available)

:: "Using IP Agreements to promote the objectives of Public Private Partnerships in developing affordable products for developing countries" by Warren Kaplan
(now available)

:: "What has been achieved, what have been the constraints and what are the future priorities for pharmaceutical product-related R&D to the reproductive health needs of developing countries?" by Peter Hall
(now available)

:: Drug Regulation and Incentives for Innovation: The Case of ASEAN by Sauwakon Ratanawijitrasin
(now available)

The views expressed in these studies are solely the responsibility of the authors and do not necessarily represent the views of the World Health Organization or the Commission on Intellectual Property Rights, Innovation and Public Health.